🔗 Share this article

A shadow economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Elimination

According to TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.

After minutes of joining one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, posts show dark colored packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant health risks”.